Tue, 06th Apr 2021 17:26
Syncona Ltd - life sciences investor managed by Syncona Investment Management Ltd - Non-Executive Director Thomas Henderson sells 317,961 shares via Farla Ltd at GBP2.50, while Chris Hollowood, chief investment officer of SIML, sells 299,700 shares at GBP2.52, both on Thursday last week and together worth GBP1.6 million.
Current stock price: 248.00 pence
Year-to-date change: down 5.0%
By Tom Waite; thomaslwaite@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
(Alliance News) - Syncona Ltd on Friday noted that Autolus Therapeutics PLC reported an increased loss amid higher operating costs.
Syncona Ltd on Thursday - London-based investor in healthcare companies - Says UK portfolio company Freeline Therapeutics Ltd presents positive new da...
(Sharecast News) - Life science investor Syncona reported positive findings from its portfolio company Freeline Therapeutics on Thursday, after a phas...
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:
(Alliance News) - Syncona Ltd on Thursday said it has reached an agreement to sell one of its portfolio companies to US biotechnology firm, Century Th...
Syncona (SYNC)